Proteomics: Beyond the Genome

IBM and MDS are building a giant database devoted to protein interactions. Here's a chat with the developer, who sees it as the next big thing in medicine

Now that the fanfare over completion of the map of human genes has died down, the hard work of making sense of the genome begins. Much of that work will revolve around what genes produce -- proteins. Proteomics, the study of interactions between proteins, is the key to understanding how our bodies stay healthy. Drug researchers consider a comprehensive catalogue of proteomics as the next Holy Grail in the genomic field.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.